Health TrialsbyHealthPanel

Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

ConditionSarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorVanderbilt-Ingram Cancer Center

About this trial

This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Parent/primary caregiver of patient

Sibling of patient aged 8 years or older

Disqualifiers

None

Trial population

Patients at any age with a history of sarcoma, with or without evidence of a persistent disease and parent/caregiver of pediatric patients and siblings of patients 8 years or older

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Surveys

    Other intervention

    Complete surveys

  • Blood Collection

    Other intervention

    Undergo blood collection

  • Saliva Collection

    Other intervention

    Undergo salvia collection

  • Urine Collection

    Other intervention

    Undergo urine collection

  • Stool Collection

    Other intervention

    Undergo stool collection

  • Tissue collection

    Other intervention

    Undergo tissue collection

  • Physical Activity Monitoring

    Other intervention

    FitBit will be worn to track physical activity

Treatment groups

2,100 Participants
are divided into 1 treatment group
Group A: Observational7 interventions

Trial outcomes

Primary outcomes

1

Impact of disease on adverse oncologic outcomes

Medical record review of Common Terminology Criteria for Adverse Events (CTCAEs)

Time frame
Approximately six years
2

Impact of treatment on adverse oncologic outcomes

Medical record review of Common Terminology Criteria for Adverse Events (CTCAEs)

Time frame
Approximately six years
3

Impact of sociodemographic contributors on adverse oncologic outcomes

Patient-Reported Outcomes Measurement Information System (PROMIS) Scores

Time frame
Approximately six years
4

Impact of lifestyle contributors on adverse oncologic outcomes

Patient-reported outcome

Time frame
Approximately six years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vanderbilt-Ingram Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov
Apply now